Advertisement
 

Study Looks at Efficacy of Hemoglobin Thresholds for Transfusion

In HealthDay News
by Healthday

30-day risk for death/MI increased with lower hemoglobin thresholds for transfusion in patients with acute MI, anemia

By Elana Gotkine HealthDay Reporter

TUESDAY, Oct. 1, 2024 (HealthDay News) — For patients with acute myocardial infarction (MI) and anemia, 30-day risks for death or recurrent MI seem to increase with lower hemoglobin thresholds for transfusion, according to a study published online Oct. 1 in the Annals of Internal Medicine.

Gerard T. Portela, Ph.D., from the University of Pittsburgh, and colleagues estimated the efficacy of four individual hemoglobin thresholds (

The researchers found that the 30-day risk for death or recurrent MI (death/MI) was 14.8, 15.1, 15.9, and 18.3 percent for a

“The imprecision of these estimates, however, prevents explicit recommendations about individual hemoglobin transfusion thresholds,” the authors write.

Editorial (subscription or payment may be required)

Copyright © 2024 HealthDay. All rights reserved.